Efficacy of XOMA 052 anti-IL-1β antibody in the DBA/1 mouse collagen-induced arthritis model

被引：1
|
作者：
Owyang, Alex [1 ]
Esposito, Lin [1 ]
Vanegas, Sandra [1 ]
Mosat, Linda [1 ]
Pongo, Elizabeth [1 ]
Larsen, Paul [1 ]
Corbin, John [1 ]
Ahluwalia, Kiron [1 ]
Roell, Marina [1 ]
Horwitz, Arnold [1 ]
Haak-Frendscho, Mary [1 ]
Dubois-Stringfellow, Nathalie [1 ]
Kantak, Seema [1 ]
Alleva, David [1 ]
机构：
[1] XOMA US LLC, Berkeley, CA USA
来源：
CLINICAL IMMUNOLOGY | 2008年 / 127卷
关键词：
D O I：
10.1016/j.clim.2008.03.277
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [1] Efficacy of XOMA 052 anti-IL-10 antibody in the DBA/1 mouse collagen-induced arthritis model
    Owyang, Alexander M.
    Esposito, Lin
    Vanegas, Sandra
    Gross, Lisa
    Masat, Linda
    Corbin, John
    Roell, Marina
    Horwitz, Arnold
    Haak-Frendscho, Mary
    Kantak, Seerna
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S265 - S265
  • [2] XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
    Owyang, Alexander M.
    Maedler, Kathrin
    Gross, Lisa
    Yin, Johnny
    Esposito, Lin
    Shu, Luan
    Jadhav, Jaaee
    Domsgen, Erna
    Bergemann, Jennifer
    Lee, Steve
    Kantak, Seema
    ENDOCRINOLOGY, 2010, 151 (06) : 2515 - 2527
  • [3] AMELIORATION OF ESTABLISHED COLLAGEN-INDUCED ARTHRITIS (CIA) WITH ANTI-IL-1
    JOOSTEN, LAB
    HELSEN, MMA
    VANDELOO, FAJ
    VANDENBERG, WB
    AGENTS AND ACTIONS, 1994, 41 : C174 - C176
  • [4] XOMA 052, an Anti-IL-1β Antibody, Improves Glucose Control, β-Cell Function, and Insulin Resistance in the Diet-Induced Obesity Mouse Model
    Owyang, Alexander M.
    Gross, Lisa
    Yin, Johny
    Lee, Steve
    Shu, Luan
    Bergemann, Jennifer
    Jadhav, Jaaee
    Esposito, Lin
    Maedler, Kathrin
    Kantak, Seema
    DIABETES, 2009, 58 : A82 - A82
  • [5] AMELIORATION OF ESTABLISHED MURINE COLLAGEN-INDUCED ARTHRITIS WITH ANTI-IL-1 TREATMENT
    VANDENBERG, WB
    JOOSTEN, LAB
    HELSEN, M
    VANDELOO, FAJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 95 (02): : 237 - 243
  • [6] XOMA-052 Humanized Anti-IL-1β Monoclonal Antibody Treatment of Diabetes Treatment of Rheumatoid Arthritis Treatment of Cardiovascular Disorders
    Krakowski, Michelle L.
    Horwitz, Marc S.
    DRUGS OF THE FUTURE, 2010, 35 (07) : 553 - 556
  • [7] XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases
    Nature Reviews Drug Discovery, 2011, 10 : 166 - 166
  • [8] XOMA 052, an Anti-IL-1β Monoclonal Antibody, Prevents IL-1β-Mediated Insulin Resistance in 3T3-L1 Adipocytes
    Handa, Masahisa
    Vanegas, Sandra
    Maddux, Betty A.
    Mendoza, Nerissa
    Zhu, Shirley
    Goldfine, Ira D.
    Mirza, Amer M.
    OBESITY, 2013, 21 (02) : 306 - 309
  • [9] DEAL WATCH XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (03) : 166 - 166
  • [10] Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice - A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra
    Joosten, LAB
    Helsen, MMA
    vandeLoo, FAJ
    vandenBerg, WB
    ARTHRITIS AND RHEUMATISM, 1996, 39 (05): : 797 - 809
12345